INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,669 Cr | ₹1,541 Cr | ₹1,242 Cr | ₹1,107 Cr | ₹968 Cr |
What is the latest Revenue of INDOCO REMEDIES ?
Year | Revenue |
---|---|
Mar2024 | ₹1,669 Cr |
Mar2023 | ₹1,541 Cr |
Mar2022 | ₹1,242 Cr |
Mar2021 | ₹1,107 Cr |
Mar2020 | ₹968 Cr |
How is Revenue of INDOCO REMEDIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,669 Cr | 8.30 | |
Mar2023 | ₹1,541 Cr | 24.10 | |
Mar2022 | ₹1,242 Cr | 12.19 | |
Mar2021 | ₹1,107 Cr | 14.26 | |
Mar2020 | ₹968 Cr | - |
Compare Revenue of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,984.1 Cr | -3.8% | -3.3% | -14% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | -3.8% |
-3.3% |
-14% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses